GlassScriptPhysician profile
Robert G Kayser
NPI 1346260999
$38,789.29
in general payments reported to CMS, 2019-2025
46 companies · $1,060 in 2025
The $1,060 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $3,523 · 2021: $7,638 · 2022: $7,065 · 2023: $2,596 · 2024: $3,851 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,330 · Food and Beverage: $3,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,330.00 |
| Food and Beverage | $3,176.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $32,251.71 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $875.90 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $755.18 | 2019-2024 | Farxiga, Lynparza |
| Medtronic, INC. | $575.41 | 2021-2025 | Symplicity G3, Ffrangio, Onyx Frontier |
| Actelion Pharmaceuticals US, INC. | $510.94 | 2019-2024 | Uptravi |
| Abbott Laboratories | $490.62 | 2020-2025 | Aveir, Cardiomems, Navitor |
| Amgen INC. | $429.41 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $387.97 | 2019-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| Sanofi-Aventis U.S. LLC | $231.06 | 2019-2024 | |
| Pfizer INC. | $222.87 | 2019-2025 | |
| Cardiovascular Systems INC. | $205.77 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.25 | 2020-2024 | Jardiance |
| Amarin Pharma, INC. | $172.98 | 2020-2022 | |
| Abiomed | $153.91 | 2023 | Impella |
| Imperative Care, INC | $119.39 | 2025 | Symphony Catheter |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $117.06 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $105.25 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.84 | 2019-2021 | |
| Novo Nordisk INC | $92.19 | 2021-2025 | Ozempic, Rybelsus |
| Kowa Pharmaceuticals America, INC. | $81.94 | 2019-2021 | |
| Stryker Corporation | $72.86 | 2025 | Flowtriever |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.76 | 2020-2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $47.77 | 2023 | Inpefa |
| Angiodynamics, INC. | $44.04 | 2025 | Auryon Laser System 100-120 Vac |
| Siemens Medical Solutions USA, INC. | $43.94 | 2023-2025 | Acuson Sc2000 Diagnostic Ultrasound System, Naeotom Alpha |
| Merck Sharp & Dohme LLC | $33.89 | 2023-2024 | Winrevair |
| Kiniksa Pharmaceuticals, LTD. | $31.69 | 2022-2023 | Arcalyst |
| W. L. Gore & Associates, INC. | $30.16 | 2020 | |
| Bard Peripheral Vascular, INC. | $30.10 | 2019-2020 | |
| Biotronik INC. | $30.10 | 2021 | |
| Horizon Therapeutics Plc | $28.66 | 2023 | Krystexxa |
| Arbor Pharmaceuticals, INC. | $27.53 | 2019 | |
| Livanova USA, INC. | $26.21 | 2019 | |
| United Therapeutics Corporation | $25.24 | 2021 | |
| Chiesi USA, INC. | $25.10 | 2019-2020 | |
| G Medical Diagnostic Services, INC. | $20.76 | 2019 | |
| Azurity Pharmaceuticals, INC. | $20.25 | 2023 | Edarbi |
| Scpharmaceuticals INC. | $18.40 | 2025 | |
| Lundbeck LLC | $14.78 | 2019 | |
| Akcea Therapeutics, INC. | $14.55 | 2020 | |
| Tactile Systems Technology INC | $13.50 | 2020 | |
| Acarix USA INC. | $13.25 | 2023 | Cadscor System |
| Portola Pharmaceuticals, LLC | $12.80 | 2019 | |
| Esperion Therapeutics, INC. | $12.78 | 2023 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $12.55 | 2019 | |
| Cvrx, INC. | $5.97 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kayser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.